Dr Reddy's, Biocon among 6 drug companies in race for Curatio

The second round of bids are expected by March-end, the sources said. Investment banks Edelweiss and Mape Advisory are running the sale process. Leading investors ChrysCapital, Sequoia and the promoters plan to sell Curatio Healthcare, at a valuation of ₹2,000-2,300 crore ($300 million), ET first reported in January. Feelers were sent to top buyout funds and domestic pharma majors such as Dr Reddy's, Torrent and Cadila Healthcare.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/gY17hNC
via IFTTT